3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
7
cyclopia sequence
6
Polycystic Ovary Syndrome
4
Fatigue
4
Obesity
3
Multiple Myeloma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Neoplasms, Plasma Cell
2
Hematologic Diseases
2
Head and Neck Neoplasms
2
Depression
2
Weight Loss
1
Warts
1
Vomiting
1
Vitamin D Deficiency
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sleepiness
1
Sezary Syndrome
1
Prostatic Intraepithelial Neoplasia
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Peripheral Nervous System Diseases
1
Periampullary Carcinoma Nos
1
Interventions
Sirolimus
6
Everolimus
5
saracatinib
1
nintedanib
1
Urination
1
Sugars
1
Simvastatin
1
Resveratrol
1
Octreotide
1
Letrozole
1
Imatinib Mesylate
1
Hydroxychloroquine
1
Glutamine
1
Doxycycline
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphangioleiomyomatosis
×
Sugars
×
Clear all
NCT01353209
2024-04-17
TRAIL
University of Cincinnati
Phase 2
Completed
17 enrolled
13 charts